Handelsbanken Fonder AB Acquires New Stake in Oscar Health, Inc. (NYSE:OSCR)

Handelsbanken Fonder AB acquired a new stake in Oscar Health, Inc. (NYSE:OSCR) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 12,000 shares of the company’s stock, valued at approximately $110,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Amalgamated Bank raised its holdings in shares of Oscar Health by 10.6% in the 3rd quarter. Amalgamated Bank now owns 15,762 shares of the company’s stock valued at $88,000 after buying an additional 1,516 shares during the period. Arizona State Retirement System raised its holdings in shares of Oscar Health by 10.4% in the 3rd quarter. Arizona State Retirement System now owns 36,520 shares of the company’s stock valued at $203,000 after buying an additional 3,440 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of Oscar Health by 19.5% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 24,569 shares of the company’s stock valued at $137,000 after buying an additional 4,011 shares during the period. LVW Advisors LLC raised its holdings in shares of Oscar Health by 34.3% in the 4th quarter. LVW Advisors LLC now owns 21,009 shares of the company’s stock valued at $192,000 after buying an additional 5,366 shares during the period. Finally, Federated Hermes Inc. raised its holdings in shares of Oscar Health by 1.9% in the 4th quarter. Federated Hermes Inc. now owns 295,687 shares of the company’s stock valued at $2,706,000 after buying an additional 5,588 shares during the period. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Wall Street Analysts Forecast Growth

OSCR has been the topic of several research analyst reports. TheStreet upgraded Oscar Health from a “d” rating to a “c-” rating in a report on Wednesday, February 21st. Raymond James initiated coverage on Oscar Health in a report on Friday, March 22nd. They set an “outperform” rating and a $20.00 price target on the stock. Wells Fargo & Company upped their price target on Oscar Health from $12.00 to $20.00 and gave the stock an “overweight” rating in a report on Thursday, February 15th. Finally, The Goldman Sachs Group upped their price target on Oscar Health from $8.00 to $16.00 and gave the stock a “neutral” rating in a report on Friday, February 9th. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $13.50.

Oscar Health Trading Down 0.4 %

NYSE:OSCR opened at $18.02 on Friday. The stock has a 50-day simple moving average of $15.27 and a 200-day simple moving average of $11.58. The stock has a market cap of $4.14 billion, a P/E ratio of -15.02 and a beta of 1.66. Oscar Health, Inc. has a 1 year low of $4.72 and a 1 year high of $18.69. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.19 and a current ratio of 1.19.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Wednesday, February 7th. The company reported ($0.66) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.74) by $0.08. The business had revenue of $1.43 billion during the quarter, compared to analysts’ expectations of $1.43 billion. Oscar Health had a negative return on equity of 29.99% and a negative net margin of 4.62%. The business’s quarterly revenue was up 43.9% compared to the same quarter last year. During the same period in the prior year, the firm posted ($1.05) EPS. As a group, analysts anticipate that Oscar Health, Inc. will post -0.23 earnings per share for the current fiscal year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.